Kasia Malinowska-Sempruch

Director, Global Drug Policy Program, Open Society Foundations

Kasia Malinowska is the founding director of the Global Drug Policy Program at the Open Society Foundations, which promotes drug policies rooted in human rights, social justice, and public health. Malinowska previously led the Open Society’s International Harm Reduction Development program, which supports the health and human rights of people who use drugs.

Before joining the Open Society Foundations, Malinowska worked for the United Nations Development Program in New York and Warsaw, leading capacity building and drug and HIV policy reform in Central and Eastern Europe and the former Soviet Union.

Malinowska publishes regularly on drug policy as it relates to women, social justice, health, human rights, civil society, and governance. Her academic publications include works in the Lancet, the British Medical Journal, and the International Journal on Drug Policy. Malinowska wrote her doctoral dissertation on “HIV among Drug Users in Poland: The Paradoxes of an Epidemic.”

Malinowska coauthored Poland’s first National AIDS program; helped formulate policy at the Global Fund to Fight AIDS, Tuberculosis, and Malaria; the World Health Organization; and the Millennium Project Task Force on HIV/AIDS, TB, and Malaria.

Malinowska holds an MSW from the University of Pennsylvania and a DrPH from Columbia University.
What We Did Right in Drug Policy During

What We Did Right in Drug Policy During 2015

Real drug policy changes are possible. As we've seen this year, they often happen at the national level, and UNGASS will be an important moment to think about our collective approach to drugs and drug use, to challenge the prohibitionist regimes that undermine human rights, social justice, and public health. Reform-minded nations like the ones highlighted above can be leaders in that process.
29/12/2015 09:28 GMT
Doctor Drug Czar - Give Public Health a Voice in Drug

Doctor Drug Czar - Give Public Health a Voice in Drug Policy

The world is used to identifying the drug war as a US project. A long-time bankroller and cheerleader for punitive drug policies, the United States is typically viewed as a defender of the status quo. But change is in the air in American drug policy.
18/09/2013 11:34 BST
'Legal Highs' and the Dangers of Bad

'Legal Highs' and the Dangers of Bad Laws

The governments in Europe can and should be expected to keep a watchful eye on new and potentially harmful substances and take legislative action if necessary. But they should also be careful to avoid inadvertently provoking the creation of an even more dangerous marketplace for 'designer drugs'.
06/08/2012 17:15 BST
Sensible Drug Policies: Will Evidence Finally Overtake

Sensible Drug Policies: Will Evidence Finally Overtake Prejudice?

One hundred years after the first international drug control treaty was signed the failure of the "war on drugs" is indisputable. In Europe two distinct trends are emerging around how countries are choosing to tackle drug policy; a punitive, criminalization approach--which is failing dramatically and expensively--or one based on scientific evidence and harm reduction--which is bearing fruits.
20/07/2012 16:54 BST
Online Debate Breaks Global Drug Policy Reform

Online Debate Breaks Global Drug Policy Reform Taboo

Last year, the <a href="http://www.globalcommissionondrugs.org/" target="_hplink">Global Commission on Drug Policy </a>called for an open debate on the global war on drugs. On Tuesday night, they went a long way to achieving this objective.
18/03/2012 18:46 GMT